Dexamethasone is Used for treating eye conditions such as diabetic macular edema, macular edema, non-infectious uveitis, and uveitis by delivering an ocular implant. It was first introduced by Merck And Co Inc in its drug Decadron on Approved Prior to Jan 1, 1982. Other drugs containing Dexamethasone are Decaderm, Hexadrol, Hemady, Ozurdex, Dextenza, Maxidex, Decaspray, Dexycu Kit. 37 different companies have introduced drugs containing Dexamethasone.

Dexamethasone Patents

Given below is the list of patents protecting Dexamethasone, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Dextenza	US12144889	Methods of treating allergic conjunctivitis	Apr 26, 2041	Ocular Therapeutix
Dexycu Kit	US11097061	Systems, kits and methods for loading and delivering a small volume dose from a syringe	Jun 23, 2039	Eyepoint Pharms
Hemady	US10537585	Compositions comprising dexamethasone	Dec 18, 2037	Dexcel
Hemady	US11304961	Compositions comprising dexamethasone	Dec 18, 2037	Dexcel
Dextenza	US11458041	Punctal plug and bioadhesives	Nov 16, 2037	Ocular Therapeutix
Dextenza	US12150896	Punctal plug and bioadhesives	Oct 07, 2036	Ocular Therapeutix
Dexycu Kit	US10022502	Dose guides for injection syringe	Jun 22, 2034	Eyepoint Pharms
Dexycu Kit	US10028965	Use of sustained release dexamethasone in post-cataract surgery inflammation	May 23, 2034	Eyepoint Pharms
Dexycu Kit	US10159683	Use of sustained release dexamethasone in post-cataract surgery inflammation	May 23, 2034	Eyepoint Pharms
Dexycu Kit	US10799642	Dose guides for injection syringe	May 11, 2032	Eyepoint Pharms
Dextenza	US8409606	Drug delivery through hydrogel plugs	May 14, 2030	Ocular Therapeutix
Dextenza	US8563027	Drug delivery through hydrogel plugs	Feb 12, 2030	Ocular Therapeutix
Dextenza	US9254267	Composite hydrogel drug delivery systems	Sep 11, 2024 (Expired)	Ocular Therapeutix
Ozurdex	US6899717	Methods and apparatus for delivery of ocular implants	Nov 01, 2023 (Expired)	Abbvie
Dexycu Kit	US6960346	Vehicles for delivery of biologically active substances	Jul 03, 2023 (Expired)	Eyepoint Pharms
Ozurdex	US10076526	Ocular implant made by a double extrusion process	Jan 09, 2023 (Expired)	Abbvie
Ozurdex	US10702539	Ocular implant made by a double extrusion process	Jan 09, 2023 (Expired)	Abbvie
Ozurdex	US8034366	Ocular implant made by a double extrusion process	Jan 09, 2023 (Expired)	Abbvie
Ozurdex	US8034370	Ocular implant made by a double extrusion process	Jan 09, 2023 (Expired)	Abbvie
Ozurdex	US8506987	Ocular implant made by a double extrusion process	Jan 09, 2023 (Expired)	Abbvie
Ozurdex	US9192511	Ocular implant made by a double extrusion process	Jan 09, 2023 (Expired)	Abbvie
Dexycu Kit	US7560120	Vehicles for delivery of biologically active substances	Sep 05, 2022 (Expired)	Eyepoint Pharms
Ozurdex	US7767223	Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use	Nov 28, 2021 (Expired)	Abbvie
Ozurdex	US6726918	Methods for treating inflammation-mediated conditions of the eye	Oct 20, 2020 (Expired)	Abbvie
Ozurdex	US7033605	Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor	Oct 20, 2020 (Expired)	Abbvie
Ozurdex	US8043628	Methods for reducing edema	Oct 20, 2020 (Expired)	Abbvie
Ozurdex	US8063031	Implants and methods for treating inflammation-mediated conditions of the eye	Oct 20, 2020 (Expired)	Abbvie
Ozurdex	US8088407	Method for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor	Oct 20, 2020 (Expired)	Abbvie
Ozurdex	US9012437	Implants and methods for treating inflammation-mediated conditions of the eye	Oct 20, 2020 (Expired)	Abbvie
Ozurdex	US9283178	Methods for treating edema in the eye and intraocular implants for use therefor	Oct 20, 2020 (Expired)	Abbvie
Ozurdex	US9592242	Methods for treating edema in the eye and intraocular implants for use therefor	Oct 20, 2020 (Expired)	Abbvie
Ozurdex	US9775849	Implants and methods for treating inflammation-mediated conditions of the eye	Oct 20, 2020 (Expired)	Abbvie

Add above patents to watchlist

Dexamethasone's Family Patents

Full family tree

Dexamethasone Generic API Manufacturers

Several generic applications have been filed for Dexamethasone. The first generic version for Dexamethasone was by Watson Laboratories Inc and was approved on Approved Prior to Jan 1, 1982. And the latest generic version is by Corepharma Llc and was approved on Sep 17, 2024.

Given below is the list of companies who have filed for Dexamethasone generic, along with the locations of their manufacturing plants worldwide.